Abiopharma

🔍 Buehler Patrick James (Executive)

Company: FIRST SOLAR, INC. (FSLR)

Report Date: 2026-03-13

Detailed Transactions and Holdings:

• Acquired 427 shares of Common Stock (Direct)
  Date: 2026-03-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,268.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 180 shares of Common Stock at $200.8 per share (Direct)
  Date: 2026-03-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,088.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 427 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 427.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4

Footnotes:

• F1: Represents shares of common stock issued upon vesting of 20% of the restricted stock units granted on March 15, 2022.
• F2: Represents shares of common stock sold by the Issuer to satisfy certain tax withholding obligations with the vesting of the restricted stock units.
• F3: Each restricted stock unit represents the right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2020 Omnibus Incentive Compensation Plan.
• F4: The restricted stock units were granted on March 15, 2022 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 15, 2022 are scheduled to vest annually at a rate of 20% on each anniversary of the grant date, commencing on the first anniversary of the grant date.